Harbin Pharmaceutical Group Co Ltd (600664)

Shanghai

Currency in CNY

9.01

+0.10(+1.12%)

Closed·02:59:59

Fair Value

Unlock Value

Day's Range

8.78

9.05

52 wk Range

2.84

9.14

600664 Income Statement

Assess the Harbin Pharm income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the 600664 net worth.

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

12,802.02

13,808.76

15,456.58

16,175.86

15,964.06

Total Revenues Growth

aa.aa

+18.66%

+7.86%

+11.93%

+4.65%

-1.31%

Cost Of Revenues

aa.aa

9,826.29

10,446.16

11,443.2

11,655.3

11,849.86

Gross Profit

aa.aa

2,975.72

3,362.61

4,013.38

4,520.56

4,114.21

Gross Profit Growth

aa.aa

+32.53%

+13%

+19.35%

+12.64%

-8.99%

Gross Profit Margin %

aa.aa

23.24%

24.35%

25.97%

27.95%

25.77%

Other Operating Expenses, Total

aa.aa

2,527.94

2,804.7

3,394.94

3,670.84

3,541.95

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-17.08%	+10.95%	+21.04%	+8.13%	-3.51%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	97.73	115.81	106.02	136.43	145.01
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	2,317.03	2,566.24	3,168.75	3,426.12	3,284.52
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	113.17	122.65	120.17	108.29	112.43

Operating Income

aa.aa

447.79

557.91

618.44

849.71

572.25

Operating Income Growth

aa.aa

+155.74%

+24.59%

+10.85%

+37.4%

-32.65%

EBIT Margin %

aa.aa

3.5%

4.04%

5.25%

3.58%

Net Interest Expenses

aa.aa

-88.66

-16.34

-4.89

-10.6

-18.21

Net Interest Expenses Growth

aa.aa

-1,030.04%

+81.57%

+70.09%

-116.87%

-71.72%

Interest Expense, Total

aa.aa

-105.16

-85.53

-56.47

-60.07

-42.55

Interest And Investment Income

aa.aa

16.5

69.19

51.58

49.47

24.35

Other Non Operating Expenses, Total

aa.aa

-3.07

-16.44

-28.1

60.93

-34.91

EBT, Excl. Unusual Items

aa.aa

356.06

525.13

585.45

900.04

519.13

Gain (Loss) On Sale Of Assets

aa.aa

210.87

161.38

0.98

0.94

3.52

Other Unusual Items, Total

aa.aa

63.61

34.65

64.12

-25.98

50.85

EBT, Incl. Unusual Items

aa.aa

630.53

701.15

650.54

875.01

572.74

EBT, Incl. Unusual Items Growth

aa.aa

+165.09%

+11.2%

-7.22%

+34.5%

-34.54%

EBT, Incl. Unusual Items Margin

aa.aa

4.93%

5.08%

4.21%

5.41%

3.59%

Income Tax Expense

aa.aa

220.69

188.94

176.32

184.4

173.96

Net Income to Company

aa.aa

409.85

512.21

474.22

690.61

398.78

Minority Interest

aa.aa

-38.76

-47.06

-78.95

-61.76

-37.18

Net Income

aa.aa

371.08

465.15

395.26

628.85

361.6

Net Income Growth

aa.aa

+134.43%

+25.35%

-15.02%

+59.1%

-42.5%

Net Income Margin %

aa.aa

2.9%

3.37%

2.56%

3.89%

2.27%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

371.08

465.15

395.26

628.85

361.6

Basic EPS - Continuing Operations

aa.aa

0.15

0.19

0.16

0.25

0.14

Basic EPS - Continuing Operations Growth

aa.aa

+134.88%

+26.67%

-15.79%

+56.25%

-44%

Diluted EPS - Continuing Operations

aa.aa

0.15

0.18

0.16

0.25

0.14

Diluted EPS - Continuing Operations Growth

aa.aa

+134.88%

+20%

-11.11%

+56.25%

-44%

Basic Weighted Average Shares Outstanding

aa.aa

2,473.89

2,448.16

2,470.4

2,515.39

2,582.84

Diluted Weighted Average Shares Outstanding

aa.aa

2,473.89

2,584.17

2,470.4

2,515.39

2,582.84

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

716.99

821.32

878.27

1,090.48

789.31

EBITDA Growth

aa.aa

+265.38%

+14.55%

+6.93%

+24.16%

-27.62%

EBITDA Margin %

aa.aa

5.6%

5.95%

5.68%

6.74%

4.94%

EBIT

aa.aa

447.79

557.91

618.44

849.71

572.25

* In Millions of CNY (except for per share items)

FAQ

What was Harbin Pharm’s revenue at year end?

At the end of the last reported fiscal year, Harbin Pharm (600664) recorded total revenue of 15,964.06 million CNY.

How much revenue did Harbin Pharm report in the most recent quarter?

In its most recent quarterly earnings report, Harbin Pharm posted revenue of 4,175.17 million CNY.

What was Harbin Pharm’s net income for the year?

For the full year, Harbin Pharm reported net income of 361.60 million CNY.

How much net income did Harbin Pharm post in the last quarter?

In the most recent quarter, Harbin Pharm (600664) posted net income of 161.13 million CNY.

What was Harbin Pharm’s gross profit for the year?

Gross profit for the year was reported at 4,114.21 million CNY.

How much gross profit did Harbin Pharm generate last quarter?

Harbin Pharm recorded gross profit of 1,006.52 million CNY in its latest quarterly report.

What was Harbin Pharm’s annual operating income?

For the full year, Harbin Pharm (600664) reported operating income of 572.25 million CNY.

What was Harbin Pharm’s operating income last quarter?

Quarterly operating income was 219.91 million CNY.

What was Harbin Pharm’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 274.17 million CNY.

What was the quarter-over-quarter change in EBITDA for Harbin Pharm?

EBITDA changed by 91.69% million CNY compared to the last quarter.

What is Harbin Pharm’s most recent gross profit margin?

The latest reported gross profit margin for Harbin Pharm (600664) is 24.11% million CNY.

What is Harbin Pharm’s most recent net income margin?

Net income margin based on recent financials is 3.86% million CNY.

What is Harbin Pharm’s most recent EBIT margin?

Harbin Pharm reported an EBIT margin of 5.27% million CNY based on current figures.

How did Harbin Pharm’s revenue change compared to the previous quarter?

Revenue changed by 5.89% million CNY compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Harbin Pharm?

In the latest quarter, gross profit changed by 2.11% million CNY from the previous quarter.

S&P/TSX

36,767.20

+36.93

+0.10%

S&P/TSX 60

2,165.89

+1.66

+0.08%

US 30

53,591.50

-141.0

-0.26%

US 500

7,773.70

-12.0

-0.15%

S&P 500 VIX

15.04

+0.79

+5.54%

DAX

26,409.64

-23.22

-0.09%

Dollar Index

99.34

-0.219

-0.22%

Market Movers

Name	Last	Chg. %	Vol.
Magna Intl	97.88	+0.33%	2.62M
Fortis Inc	78.30	-0.48%	2.31M
Enbridge	70.60	-0.01%	2.15M
Quebecor B	65.58	-0.02%	1.87M
RBC	301.60	+0.30%	155.83K
Shopify Inc	208.05	-2.94%	219.60K
Bank of Montreal	259.06	+0.46%	162.82K

Name	Last	Chg. %	Vol.
Winchester Equity	0.015	+50.00%	100.00K
Vendetta Mining	0.0150	+50.00%	9.00K
Winchester Equity	0.02	+50.00%	1.63M
Good Gamer Entertainment	0.14	+47.37%	22.00K
CanAsia Energy	0.400	+37.93%	1.08M
CanAsia Energy	0.42	+33.87%	8.00K
Capitan Investment	0.020	+33.33%	1.00K

Name	Last	Chg. %	Vol.
Keek Social	0.700	-49.64%	218.00
Western Metallica Resources	0.13	-35.00%	1.67K
Abacus Mining	0.02	-25.00%	23.86K
Sendero Resources	0.89	-23.93%	98.02K
Millennium Silver	0.020	-20.00%	107.12K
Falcon Gold	0.0250	-16.67%	18.36K
Reko International	4.43	-15.62%	2.20K

Trending Stocks

Name	Last	Chg. %	Vol.
HIVE Digital Tech	4.0900	+9.95%	2.35M
Keel Infra	5.21	+6.98%	1.49M
Celestica Inc.	471.81	+1.41%	30.06K
Canadian Natural	67.29	+1.33%	268.41K
Toronto Dominion Bank	173.55	+0.54%	208.31K

Most Undervalued Stocks

Name	Last	Upside	Fair Value
A A A Aa A A	131.64	+52.90%	201.28
Aaaaaa	100.23	+45.96%	146.30
Aaaaaaaaaaaaaaaaaaa	8.80	+45.24%	12.78
Aaa Aaaaaaa	16.65	+44.81%	24.11
A Aaaaaaa A	30.23	+43.89%	43.50
Aaaaaaaaaa Aa	5.38	+43.06%	7.70
Aaaaaaa Aa Aaaa Aaa	33.19	+40.38%	46.59

Name	Last	Upside	Fair Value
A A A Aa A A	131.64	+52.90%	201.28
Aaaaaa	100.23	+45.96%	146.30
Aaaaaaaaaaaaaaaaaaa	8.80	+45.24%	12.78
Aaa Aaaaaaa	16.65	+44.81%	24.11
A Aaaaaaa A	30.23	+43.89%	43.50
Aaaaaaaaaa Aa	5.38	+43.06%	7.70
Aaaaaaa Aa Aaaa Aaa	33.19	+40.38%	46.59

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Harbin Pharmaceutical Group Co Ltd (600664)

600664 Income Statement

FAQ

What was Harbin Pharm’s revenue at year end?

How much revenue did Harbin Pharm report in the most recent quarter?

What was Harbin Pharm’s net income for the year?

How much net income did Harbin Pharm post in the last quarter?

What was Harbin Pharm’s gross profit for the year?

How much gross profit did Harbin Pharm generate last quarter?

What was Harbin Pharm’s annual operating income?

What was Harbin Pharm’s operating income last quarter?

What was Harbin Pharm’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Harbin Pharm?

What is Harbin Pharm’s most recent gross profit margin?

What is Harbin Pharm’s most recent net income margin?

What is Harbin Pharm’s most recent EBIT margin?

How did Harbin Pharm’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Harbin Pharm?

Trending Stocks